Changes in Hepatic Fat Content by CT 1 Year After Sleeve Gastrectomy in Adolescents and Young Adults With Obesity.


Journal

The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362

Informations de publication

Date de publication:
17 Nov 2023
Historique:
received: 16 05 2023
pmc-release: 04 07 2024
medline: 20 11 2023
pubmed: 5 7 2023
entrez: 4 7 2023
Statut: ppublish

Résumé

Obesity is associated with nonalcoholic fatty liver disease (NAFLD). Sleeve gastrectomy (SG) is an effective means of weight loss and improvement of NAFLD in adults; however, data regarding the efficacy of SG in the early stages of pediatric NAFLD are sparse. To assess the impact of SG on hepatic fat content 1 year after SG in youth with obesity compared with nonsurgical controls with obesity (NS). A 12-month prospective study in 52 participants (mean age, 18.2 ± .36 years) with obesity, comprising 25 subjects who underwent SG (84% female; median body mass index [BMI], 44.6 [42.1-47.9] kg/m2) and 27 who were NS (70% female; median BMI, 42.2 [38.7-47.0] kg/m2). Hepatic fat content by computed tomography (liver/spleen ratio), abdominal fat by magnetic resonance imaging. Mean 12-month decrease in BMI was greater in SG vs NS (-12.5 ± .8 vs -.2 ± .5 kg/m2, P < .0001). There was a within-group increase in the liver-to-spleen (L/S) ratio in SG (.13 ± .05, P = .014) but not NS with a trend for a difference between groups (P = .055). All SG participants with an L/S ratio <1.0 (threshold for the diagnosis of NAFLD) before surgery had a ratio of >1.0 a year after surgery, consistent with resolution of NAFLD. Within SG, the 12-month change in L/S ratio was negatively associated with 12-month change in visceral fat (ρ = -.51 P = .016). Hepatic fat content as assessed by noncontrast computed tomography improved after SG over 1 year in youth with obesity with resolution of NAFLD in all subjects. This was associated with decreases in visceral adiposity.

Identifiants

pubmed: 37403207
pii: 7219193
doi: 10.1210/clinem/dgad390
pmc: PMC10655539
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1489-e1495

Subventions

Organisme : NIH HHS
ID : K24DK109940
Pays : United States

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

Front Pediatr. 2016 Jul 26;4:78
pubmed: 27508205
Am J Med. 2018 Jun;131(6):684-692.e12
pubmed: 29518370
AJR Am J Roentgenol. 2010 Mar;194(3):623-8
pubmed: 20173137
J Pediatr Gastroenterol Nutr. 2017 Feb;64(2):319-334
pubmed: 28107283
Biol Sex Differ. 2018 Jun 27;9(1):28
pubmed: 29950175
Front Endocrinol (Lausanne). 2020 Mar 24;11:157
pubmed: 32265846
Gastroenterology. 2006 Jun;130(7):2023-30
pubmed: 16762625
World J Gastroenterol. 2011 Jul 28;17(28):3335-41
pubmed: 21876622
AJR Am J Roentgenol. 1984 Apr;142(4):741-6
pubmed: 6608234
Medicine (Baltimore). 2021 Jul 2;100(26):e26436
pubmed: 34190166
Gastroenterology. 2020 Oct;159(4):1290-1301.e5
pubmed: 32553765
N Engl J Med. 2016 Jan 14;374(2):113-23
pubmed: 26544725
Eur Radiol. 2011 Jan;21(1):87-97
pubmed: 20680289
Nat Rev Endocrinol. 2021 Aug;17(8):484-495
pubmed: 34131333
Aliment Pharmacol Ther. 2013 Nov;38(10):1267-77
pubmed: 24117728
Metabolism. 2019 Mar;92:82-97
pubmed: 30502373
Aliment Pharmacol Ther. 2021 Nov;54(9):1150-1161
pubmed: 34570916
J Pediatr. 2017 Jan;180:31-37.e2
pubmed: 27697327
Diabetes Metab Syndr. 2022 Jun;16(6):102539
pubmed: 35709586
Hepatology. 2010 Jun;51(6):1979-87
pubmed: 20336705
Diagnostics (Basel). 2022 Feb 04;12(2):
pubmed: 35204498
Pediatrics. 2018 Feb;141(2):
pubmed: 29311357
AJR Am J Roentgenol. 2018 Sep;211(3):W151-W157
pubmed: 30016142
J Comput Tomogr. 1981 Mar;5(1):33-5
pubmed: 7273824

Auteurs

Ana Paola López López (AP)

Neuroendocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.

Shubhangi Tuli (S)

Neuroendocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.

Meghan Lauze (M)

Neuroendocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.

Imen Becetti (I)

Neuroendocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.
Division of Pediatric Endocrinology, Massachusetts General Hospital for Children and Harvard Medical School, Boston, MA 02114, USA.

Clarissa C Pedreira (CC)

Neuroendocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.

Florian A Huber (FA)

Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Emre Omeroglu (E)

Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.

Vibha Singhal (V)

Neuroendocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.
Division of Pediatric Endocrinology, Massachusetts General Hospital for Children and Harvard Medical School, Boston, MA 02114, USA.
Pediatric Program MGH Weight Center, Massachusetts General Hospital, Boston, MA 02114, USA.

Madhusmita Misra (M)

Neuroendocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.
Division of Pediatric Endocrinology, Massachusetts General Hospital for Children and Harvard Medical School, Boston, MA 02114, USA.

Miriam A Bredella (MA)

Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH